SCHEMBL14600237

SCHEMBL14600237

Cc1ccc(C(=O)O)c(Nc2cc(C(C)(C)C)nn2-c2ccncc2)c1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 12/20 0.55
MAPK13 O15264 10/20 0.55
MAPK12 P53778 10/20 0.55
MAPK11 Q15759 9/20 0.55
PTK2 Q05397 2/20 0.52
CDK8 P49336 1/20 0.50
CYP2C8 P10632 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
JAK2 O60674 1/20 0.45
TNF P01375 1/20 0.45
HCK P08631 1/20 0.45
DDR2 Q16832 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4664181 0.91 MAPK14 (0.55) MAPK14MAPK13MAPK12MAPK11PTK2
SCHEMBL14600240 0.88 MAPK14 (0.62) MAPK14MAPK13MAPK12MAPK11PTK2
SCHEMBL14600246 0.84 MAPK13 (0.53) MAPK14MAPK13MAPK12MAPK11PTK2
SCHEMBL14600238 0.83 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11PTK2
SCHEMBL14600443 0.83 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11PTK2
SCHEMBL5010626 0.81 MAPK14 (0.61) MAPK14MAPK13MAPK12MAPK11DDR2
SCHEMBL14600243 0.81 GFER (0.53) MAPK14MAPK13MAPK12MAPK11PTK2
SCHEMBL3939655 0.81 MAPK14 (0.75) MAPK14MAPK13MAPK12MAPK11PTK2
SCHEMBL14600236 0.81 MAPK13 (0.56) MAPK14MAPK13MAPK12MAPK11PTK2
SCHEMBL3973016 0.75 KDM4C (0.47) MAPK14MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed